How integrated insights supported a biologic launch strategy across multiple indications
Our client is launching a new biologic in immunology across several indications and needed to understand the market, including the patient pool, treatment landscape, potential uptake and reimbursement as well the pricing opportunity. They wanted to use the insights to develop the optimal launch strategy across 12 markets and across indications, and also support the local market access teams by conducting a mock negotiation with payers.
New hopes for Mexico
What will be the future of healthcare under the country's new administration?
In December 2018 the new Mexican President, Andres Manuel Lopez Obrador came into office after a landslide victory of over 65% of the votes (more than 30 billion voters). López Obrador was a former Mexico City mayor and has been a major political figure for over twenty years. Widely regarded as both a populist and nationalist, his ideology is to end poverty and improve the lives of his people by fighting corruption and increasing austerity within the government.
Webcast: Rich in potential - Exploring the opportunity for nutritionals in emerging markets
A shift to preventative health has seen nutritionals emerge as a rapidly developing area in recent years. But while growth begins to level off in more established territories, attention is turning to emerging markets. Join Research Partnership's emerging market experts Paul Reed and Kira Pillai for our upcoming live webinar ‘Rich in potential: Exploring the opportunity for nutritionals in emerging markets’ in which they will explore the challenges and opportunities for the nutritionals sector in some of the world’s fastest growing markets.
Webcast: Going for growth - Maximising your return on insights in Emerging Markets
Healthcare market research in emerging markets is still evolving, so finding the insights you require and then maximising the return on those insights can be challenging. Download this complimentary webcast in which Emerging Markets Directors Marc Yates and Rachel Howard will provide you with the critical success factors to ensure actionable primary research in emerging markets.
Interactive infographic: LATAM
An overview of the six most-commonly researched, largest pharma markets in Latin America
The LATAM region's largest markets of Argentina, Brazil, Chile, Colombia, Mexico and Venezuela, is home to more than 460 million people and is a key global growth region. With pharmaceutical sales of more than $64bn, it is an attractive market for pharma, however it is also one in which each market differs in terms of opportunities and challenges.